Midatech Pharma Plc Profit margin
What is the Profit margin of Midatech Pharma Plc?
The Profit margin of Midatech Pharma Plc is -1,095.85%
What is the definition of Profit margin?
Profit margin is a measure of profitability and is calculated by finding the net profit as a percentage of the revenue.
lfy (last fiscal year)
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Profit margin of companies in the Health Care sector on LSE compared to Midatech Pharma Plc
What does Midatech Pharma Plc do?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Companies with profit margin similar to Midatech Pharma Plc
- Tempo Australia has Profit margin of -1,112.63%
- Immutep has Profit margin of -1,112.50%
- Rollatainers has Profit margin of -1,108.02%
- Asia Resources has Profit margin of -1,107.88%
- RedFlow has Profit margin of -1,101.61%
- Cellectis SA has Profit margin of -1,099.67%
- Midatech Pharma Plc has Profit margin of -1,095.85%
- Phunware Inc has Profit margin of -1,092.40%
- Mesoblast has Profit margin of -1,091.87%
- Geomega Resources has Profit margin of -1,090.91%
- Sunwah Kingsway Capital has Profit margin of -1,090.28%
- Arcimoto has Profit margin of -1,084.39%
- Neovasc has Profit margin of -1,081.36%